ARID1A and lung adenocarcinoma: To our knowledge, this is a unique case of lung adenocarcinoma with ARID1A gene alterations leading to sporadic MSI, through somatic MLH1 epigenomic changes, with an MLH1 gene mutation as the second somatic hit.